MedPath

Effect of supplementation in treatment of patients with rheumatoid arthritis

Phase 2
Conditions
Rheumatoid arthritis.
Other streptococcal arthritis and polyarthritis
M00.2
Registration Number
IRCT201611165623N94
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
54
Inclusion Criteria

Patients with rheumatoid arthritis
Aged 25 to 70 years

Exclusion Criteria

Patients who had chronic renal failure
Pregnant
Lactating women
Symptoms or personal history of cardiovascular disease, diabetes mellitus
The consumption of antihyperglycemic agents
Patients unlikely to come for follow-up in the following 3 months
Patients who are unable to read numbers and/or unable to mark the pain scale
Taking probiotics, synbiotics, antioxidant and/or anti-inflammatory supplements
Taking antibiotics

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hs-CRP. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa kit.;Nitric oxide. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Spectrophotometry.;DAS-28. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Sum scores.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath